Compare Cardinal Health Inc (CAH) vs NetFlix Inc (NFLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs NetFlix Inc — how do they compare? Cardinal Health Inc trades at $228.59 (market cap $53.89B), while NetFlix Inc trades at $73.98 (market cap $309.62B). The key difference: NetFlix Inc is far larger — about 5.7× Cardinal Health Inc's market cap, and Cardinal Health Inc pays a 0.89% dividend while NetFlix Inc pays none. Which is the better fit depends on your goals.
| CAH | NFLX | |
|---|---|---|
Market Cap | $53.89B | $309.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $239.71 | $127.42 |
52-Week Low | $146.04 | $70.91 |
Enterprise Value | $58.87B | $311.69B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Netflix (NFLX) trades at $73.83, showing modest daily gains of 0.63% but remains in a technical bearish trend. The stock demonstrates strong fundamental performance with Q1 2026 EPS beating expectations at $1.23 versus $0.763 expected, while revenue growth accelerated to 16% year-over-year. Analyst sentiment remains predominantly bullish with 66% buy ratings, though technical indicators signal near-term caution with the stock approaching key support levels.
The investment outlook balances robust fundamentals against technical headwinds. Netflix's expanding advertising business and projected $3 billion in ad revenue by 2026 provide growth catalysts, while competitive pressures and market volatility present risks. With a consensus price target of $103.64 offering 40% upside potential, the stock presents value for long-term investors despite near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →
